-
Je něco špatně v tomto záznamu ?
Léčba diabetu transplantací izolovaných Langerhansových ostrůvků
[Islet transplantation for treatment of type-1 diabetes mellitus]
František Saudek, Peter Girman, Jan Kříž, Zuzana Berková, Klára Zacharovová, Tomáš Koblas, Lenka Pektorová, Ema Vávrová, Martina Mindlová, David Habart, Jan Peregrin, Květoslav Lipár, Martin Oliverius, Eva Dovolilová, Evžena Číhalová, Vít Bobek
Jazyk čeština Země Česko
Typ dokumentu kazuistiky
Digitální knihovna NLK
Číslo
Ročník
Zdroj
Zdroj
NLK
Medline Complete (EBSCOhost)
od 2011-01-01
- Klíčová slova
- slinivka břišní, imunosuprese,
- MeSH
- diabetes mellitus 1. typu farmakoterapie chirurgie krev MeSH
- dospělí MeSH
- hypoglykemika terapeutické užití MeSH
- inzulin terapeutické užití MeSH
- komplikace diabetu MeSH
- krevní glukóza analýza MeSH
- lidé středního věku MeSH
- lidé MeSH
- transplantace Langerhansových ostrůvků metody přístrojové vybavení škodlivé účinky MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- kazuistiky MeSH
Organ pancreas transplantation represents the only method enabling long-term normalization of glucose metabolism in type-1 diabetic subjects so far. Unfortunately, surgical complications of this kind of therapy are still frequent. As a safer alternative, transplantation of isolated pancreatic islets was introduced at the Institute for Clinical and Experimental Medicine as a clinical experiment in the year 2005. METHODS AND RESULTS: We isolated the islets from pancreases of cadaveric donors which did not fulfil criteria to perform organ pancreas transplantation. Altogether, 36 islet implantations were performed in 28 C-peptide negative subjects suffering from type-1 diabetes by August 2010. In 15 subjects (21 implantations) the main indication was extremely instable course of diabetes due to the hypoglycaemia unawareness syndrome. In 5 and 3 cases, combined islet and kidney and islet and liver transplants were performed, respectively. In addition, islet autotransplantation was performed in 5 subjects undergoing total pancreatectomy. No patient died during the study period. In all but 1 patient with primary islet afunction, islet transplantation led to a complete cure of the hypoglycemia unawareness syndrome. Out of 15 patients, 11 subjects in this group showed a significant C-peptide production (> 0.2 pmol/ml) after 1 year. The mean insulin dose after allotransplantation decreased from 37 to 14 units per day and in 3 subjects, insulin therapy could be withdrawn. Serious technical complications occurred in 6 subjects, which only in 2 cases required surgical revision and did not cause long-term sequels. CONCLUSIONS: In comparison with organ pancreas transplantation, pancreatic islet transplantation represents a substantially safer method for restitution of endogenous insulin production. Though it eliminates serious hypoglycemic episodes in labile diabetes, complete insulin withdrawal is still often not possible. However, due to continuing progress in the laboratory techniques as well as in the transplant procedure itself, the results are steadily improving.
Islet transplantation for treatment of type-1 diabetes mellitus
Lit.: 20
- 000
- 00000naa 2200000 a 4500
- 001
- bmc11003780
- 003
- CZ-PrNML
- 005
- 20250325114549.0
- 008
- 110302s2011 xr e cze||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a cze $b eng
- 044 __
- $a xr
- 100 1_
- $a Saudek, František, $d 1955- $7 nlk20000083698
- 245 10
- $a Léčba diabetu transplantací izolovaných Langerhansových ostrůvků / $c František Saudek, Peter Girman, Jan Kříž, Zuzana Berková, Klára Zacharovová, Tomáš Koblas, Lenka Pektorová, Ema Vávrová, Martina Mindlová, David Habart, Jan Peregrin, Květoslav Lipár, Martin Oliverius, Eva Dovolilová, Evžena Číhalová, Vít Bobek
- 246 11
- $a Islet transplantation for treatment of type-1 diabetes mellitus
- 314 __
- $a IKEM, Klinika diabetologie, Centrum diabetologie, Praha
- 504 __
- $a Lit.: 20
- 520 9_
- $a Organ pancreas transplantation represents the only method enabling long-term normalization of glucose metabolism in type-1 diabetic subjects so far. Unfortunately, surgical complications of this kind of therapy are still frequent. As a safer alternative, transplantation of isolated pancreatic islets was introduced at the Institute for Clinical and Experimental Medicine as a clinical experiment in the year 2005. METHODS AND RESULTS: We isolated the islets from pancreases of cadaveric donors which did not fulfil criteria to perform organ pancreas transplantation. Altogether, 36 islet implantations were performed in 28 C-peptide negative subjects suffering from type-1 diabetes by August 2010. In 15 subjects (21 implantations) the main indication was extremely instable course of diabetes due to the hypoglycaemia unawareness syndrome. In 5 and 3 cases, combined islet and kidney and islet and liver transplants were performed, respectively. In addition, islet autotransplantation was performed in 5 subjects undergoing total pancreatectomy. No patient died during the study period. In all but 1 patient with primary islet afunction, islet transplantation led to a complete cure of the hypoglycemia unawareness syndrome. Out of 15 patients, 11 subjects in this group showed a significant C-peptide production (> 0.2 pmol/ml) after 1 year. The mean insulin dose after allotransplantation decreased from 37 to 14 units per day and in 3 subjects, insulin therapy could be withdrawn. Serious technical complications occurred in 6 subjects, which only in 2 cases required surgical revision and did not cause long-term sequels. CONCLUSIONS: In comparison with organ pancreas transplantation, pancreatic islet transplantation represents a substantially safer method for restitution of endogenous insulin production. Though it eliminates serious hypoglycemic episodes in labile diabetes, complete insulin withdrawal is still often not possible. However, due to continuing progress in the laboratory techniques as well as in the transplant procedure itself, the results are steadily improving.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a krevní glukóza $x analýza $7 D001786
- 650 _2
- $a diabetes mellitus 1. typu $x farmakoterapie $x chirurgie $x krev $7 D003922
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hypoglykemika $x terapeutické užití $7 D007004
- 650 _2
- $a inzulin $x terapeutické užití $7 D007328
- 650 _2
- $a transplantace Langerhansových ostrůvků $x metody $x přístrojové vybavení $x škodlivé účinky $7 D016381
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a komplikace diabetu $7 D048909
- 653 00
- $a slinivka břišní
- 653 00
- $a imunosuprese
- 655 _2
- $a kazuistiky $7 D002363
- 700 1_
- $a Girman, Peter $7 xx0081892
- 700 1_
- $a Kříž, Jan, $d 1972- $7 xx0056572
- 700 1_
- $a Berková, Zuzana $7 xx0081890
- 700 1_
- $a Zacharovová, Klára $7 xx0074471
- 700 1_
- $a Koblas, Tomáš $7 xx0070806
- 700 1_
- $a Vargová, Lenka $7 xx0141859
- 700 1_
- $a Vávrová, Ema $7 _AN049310
- 700 1_
- $a Mindlová, Martina $7 xx0092588
- 700 1_
- $a Habart, David $7 xx0035016
- 700 1_
- $a Peregrin, Jan H., $d 1951- $7 mzk2006331741
- 700 1_
- $a Lipár, Květoslav $7 xx0231456
- 700 1_
- $a Oliverius, Martin $7 xx0106430
- 700 1_
- $a Dovolilová, Eva $7 xx0077055
- 700 1_
- $a Číhalová, Eugenie $7 xx0260071
- 700 1_
- $a Bobek, Vít $7 xx0330470
- 773 0_
- $w MED00010976 $t Časopis lékařů českých $g Roč. 150, č. 1 (2011), s. 49-55 $x 0008-7335
- 856 41
- $u https://www.prolekare.cz/casopisy/casopis-lekaru-ceskych/2011-1-1/lecba-diabetu-transplantaci-izolovanych-langerhansovych-ostruvku-34283 $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 1 $c 1068 $y 7 $z 0
- 990 __
- $a 20110302102004 $b ABA008
- 991 __
- $a 20250325114549 $b ABA008
- 999 __
- $a ok $b bmc $g 830989 $s 695803
- BAS __
- $a 3
- BMC __
- $a 2011 $b 150 $c 1 $d 49-55 $m Časopis lékařů českých $x MED00010976
- LZP __
- $a 2011-14/vtme